Insmed Stock (NASDAQ: INSM) stock price, news, charts, stock research, profile.
You can purchase shares of Insmed (NASDAQ:INSM) through any online brokerage.
Other companies in Insmed’s space includes: Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).
Insmed has a consensus price target of $77.50.
The stock price for Insmed (NASDAQ: INSM) is $70.14 last updated November 12, 2024 at 4:00 PM EST.
There are no upcoming dividends for Insmed.
Insmed’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Insmed.
Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.